New Science Ventures — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Novadipnovadip.com inOct 2021✓ verified

Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.

BiotechDeep TechHealthtechMedical DevicesLouvain, BE

Dr. Denis Dufrane(Founder & Professor)in

BoardEric Paul Pâques(Chairman)

Co-investorsFund+VIVES Partners Sambrinvest Wallonie Entreprendre

Ventyx Biosciencesventyxbio.com inMar 2021 · $114M

San Diego, US

Mark S. Forman(Executive Officer)inMatthew Moore(Executive Officer)inJohn Nuss(Executive Officer)inJigar Choksey(Director)Martin Auster(Executive Officer)inChristopher W. Krueger(Executive Officer)

Co-investorsThird Point Ventures venBio Partners SilverArc Private venBio Global Strategic

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.